iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in iTeos Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 153
- +8 vs. Q4 2022
- Shares held
- 36.0M
- −203.9K (−0.6%) vs. Q4 2022
- Total value
- $488.9M
- −$218.1M (−30.9%) vs. Q4 2022
- New holders
- 25
- 45 more added
- Sold out
- 17
- 57 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 72,666 | $989.0K | 0.00% | +5,653+8.4% | Added |
| Deutsche Bank AG | 81,221 | $1.11M | 0.00% | +7,216+9.8% | Added |
| Massachusetts Financial Services Co | 83,154 | $1.13M | 0.00% | −40,708−32.9% | Reduced |
| Victory Capital Management Inc | 84,449 | $1.15M | 0.00% | +20,857+32.8% | Added |
| Sectoral Asset Management Inc | 88,373 | $1.20M | 0.23% | +30,611+53.0% | Added |
| Vontobel Holding Ltd. | 88,373 | $1.20M | 0.01% | +30,611+53.0% | Added |
| Nuveen Asset Management, LLC | 97,282 | $1.32M | 0.00% | +7,854+8.8% | Added |
| DAFNA Capital Management LLC | 98,560 | $1.34M | 0.40% | 00.0% | Unchanged |
| American Century Companies Inc | 110,290 | $1.45M | 0.00% | −62,416−36.1% | Reduced |
| Los Angeles Capital Management LLC | 107,222 | $1.46M | 0.01% | +19,024+21.6% | Added |
| LMR Partners LLP | 112,919 | $1.54M | 0.03% | +82,700+273.7% | Added |
| Rafferty Asset Management, LLC | 114,050 | $1.55M | 0.01% | +11,384+11.1% | Added |
| Panagora Asset Management Inc | 116,734 | $1.59M | 0.01% | +66,303+131.5% | Added |
| Ameriprise Financial Inc | 138,640 | $1.89M | 0.00% | +16,653+13.7% | Added |
| Wellington Management Group LLP | 148,594 | $2.02M | 0.00% | −1,953−1.3% | Reduced |
| Baker Bros. Advisors LP | 150,346 | $2.05M | 0.01% | 00.0% | Unchanged |
| Principal Financial Group Inc | 155,157 | $2.11M | 0.00% | −3,331−2.1% | Reduced |
| Prudential Financial Inc | 157,361 | $2.14M | 0.00% | +11,300+7.7% | Added |
| Bank of America Corp | 157,630 | $2.15M | 0.00% | −314,885−66.6% | Reduced |
| AQR Capital Management LLC | 176,822 | $2.41M | 0.01% | −25,521−12.6% | Reduced |
| Integral Health Asset Management, LLC | 180,000 | $2.45M | 0.51% | −90,000−33.3% | Reduced |
| Charles Schwab Investment Management Inc | 182,966 | $2.49M | 0.00% | +477+0.3% | Added |
| FMR LLC | 212,715 | $2.90M | 0.00% | −142,283−40.1% | Reduced |
| Tang Capital Management LLC | 216,700 | $2.95M | 0.44% | 00.0% | Unchanged |
| AXA S.A. | 218,600 | $2.98M | 0.01% | −496−0.2% | Reduced |
| Northern Trust Corp | 252,019 | $3.43M | 0.00% | −1,668−0.7% | Reduced |
| Barclays PLC | 256,956 | $3.50M | 0.00% | +1,995+0.8% | Added |
| Bank of New York Mellon Corp | 261,955 | $3.57M | 0.00% | −12,418−4.5% | Reduced |
| Bridgeway Capital Management, LLC | 266,945 | $3.63M | 0.10% | +23,445+9.6% | Added |
| Citigroup Inc | 288,885 | $3.93M | 0.01% | +54,589+23.3% | Added |
| Renaissance Technologies LLC | 329,900 | $4.49M | 0.01% | +12,800+4.0% | Added |
| Artal Group S.A. | 400,000 | $5.44M | 0.32% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 415,606 | $5.66M | 0.00% | +250,455+151.7% | Added |
| Goldman Sachs Group Inc | 438,109 | $5.96M | 0.00% | +11,598+2.7% | Added |
| 683 Capital Management, LLC | 480,000 | $6.53M | 0.58% | +330,000+220.0% | Added |
| Saturn V Capital Management LLC | 480,653 | $6.54M | 4.89% | +138,582+40.5% | Added |
| Geode Capital Management, LLC | 481,239 | $6.55M | 0.00% | +9,731+2.1% | Added |
| Jacobs Levy Equity Management, Inc | 514,925 | $7.01M | 0.04% | +11,395+2.3% | Added |
| JPMorgan Chase & Co | 526,157 | $7.16M | 0.00% | −57,801−9.9% | Reduced |
| Millennium Management LLC | 528,272 | $7.19M | 0.01% | −346,208−39.6% | Reduced |
| Morgan Stanley | 563,214 | $7.67M | 0.00% | −283,645−33.5% | Reduced |
| Invesco Ltd. | 588,561 | $8.01M | 0.00% | −20,039−3.3% | Reduced |
| Octagon Capital Advisors LP | 596,000 | $8.11M | 1.17% | +151,000+33.9% | Added |
| Candriam Luxembourg S.C.A. | 739,517 | $9.26M | 0.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,443,500 | $19.6M | 0.02% | +88,073+6.5% | Added |
| MPM Oncology Impact Management LP | 1,745,943 | $23.8M | 6.17% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,772,989 | $24.1M | 0.00% | −46,041−2.5% | Reduced |
| BVF Inc | 1,810,835 | $24.6M | 0.90% | 00.0% | Unchanged |
| State Street Corp | 1,827,391 | $24.9M | 0.00% | +90,101+5.2% | Added |
| Boxer Capital, LLC | 2,154,058 | $29.3M | 1.44% | 00.0% | Unchanged |
| MPM Asset Management LLC | 2,738,785 | $37.3M | 15.53% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,417,259 | $60.1M | 1.36% | 00.0% | Unchanged |
| BlackRock Inc. | 4,463,306 | $60.7M | 0.00% | −16,115−0.4% | Reduced |
| Advisors Preferred, LLC | 0 | $0 | 0.00% | −90,973−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −85,756−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −71,585−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −70,922−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −40,468−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −28,531−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −25,099−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −23,159−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −21,041−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −13,946−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −12,766−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,733−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,438−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −467−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |